Zostavax
PATIENT INFORMATION
The health care provider should question the vaccine recipient about reactions to previous vaccines (see CONTRAINDICATIONS). The health care provider should also inform the vaccine recipient of the benefits and risks of ZOSTAVAX. Patients should be provided with a copy of the Patient Information Sheet at the end of this insert, and be given an opportunity to discuss any questions or concerns.
Vaccinees should also be informed of the theoretical risk of transmitting the vaccine virus to varicella-susceptible individuals, including pregnant women who have not had chickenpox. Patients should also be told that pregnancy should be avoided for three months following vaccination.
Patients should be instructed to report any adverse reactions to their health care provider.
Generic Name: Zoster Vaccine Live
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Women's Health
Find out what women really need.
Preventing Shingles
Here's a surprising way to reduce your risk and avoid years of pain. See more WebMD Videos »
Zostavax
Health Resources
2008 Election & Health Care on WebMD. Get Informed.
Updated & New
RxList does not provide medical advice, diagnosis or treatment.